News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Product Strategies for Prefilled Syringes Diverging


Product Strategies for Prefilled Syringes Diverging to Reflect Technology Evolution

Greystone Research Associates Examines the Impact of Value-added Devices and Branding on Injectable Drugs

(Amherst, NH) - As prefilled injection devices continue to replace vials in terms of doses as well as total sector revenue, pharmaceutical and biotech program managers are increasingly integrating syringe and self-injection device technology into their development plans. The result has been a migration toward multi-functional development teams and an increasing reliance on accelerated product feasibility testing. As the factors driving this trend continue to evolve over the next six years, the number of tailored injectable drug products that reach the market will escalate.

As an elegant and utilitarian form of injectable drug packaging, prefilled syringes represent a landmark success story of the convergence of device engineering and market requirements. Prefilled syringes continue to experience double-digit annual unit growth (slightly above twelve percent in 2011). Not unexpectedly, evolution in prefilled syringe device design and technology has led to the increasing availability of devices that provide incremental value to drug marketers with product margins that afford these higher cost devices.

Improved patient compliance, efficient delivery of high-priced biologicals, and patient & caregiver safety are key market drivers in this sector. The cost of biologicals such as recombinant proteins has created interest in prefilled syringes to reduce cost and waste associated with the handling of vial-packaged drugs. Partnerships between device designers and drug developers are an essential element in the success of prefilled devices, particularly for patient self-administration.

A new and comprehensive report on global prefilled syringe markets conducted by Greystone Research Associates has just been released. The report - Prefilled Syringes to 2018: Devices, Drugs, Markets, Players and Prospects - includes analysis and assessments of prefilled syringe devices, injectable drugs, and combination products, evaluations of therapeutic markets, an examination of market factors, and profiles of market participants.

More information is available at
http://www.greystoneassociates.org

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
www.greystoneassociates.org

Source: Greystone Research Associates

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Wellington Rugby Zeroes: Sevens To Move To Hamilton

Wellington Mayor Justin Lester: “The Sevens has been a big part of recent Wellington history but it was time for the event to move on… Wellingtonians have been voting with their feet in the last few years and we’ve seen the result in dwindling crowd numbers and lower ticket sales.” More>>

ALSO:

Matafeo & Dravid: The Billy T And Fred Award Winners For 2017

At the final show of the 2017 NZ International Comedy Festival powered by Flick Electric Co. the Festival came to a close after 115 shows in Auckland and 68 shows in Wellington. More>>

Scoop Review Of Books: What’s Fair? Tax and Fairness

This is an excellent and timely book, since apart from general statements about increasing or mostly reducing tax, there has been very little comment or debate as to whether we should pay tax at all and how much tax should each of us pay. More>>

Ockham Awards: Globally Lauded Novelist Wins NZ’s Biggest Fiction Prize

Internationally renowned Ngāruawāhia resident Catherine Chidgey has won New Zealand’s richest writing award, the $50,000 Acorn Foundation Fiction Prize, for her novel The Wish Child. More>>

ALSO:

 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland